Ondine Biomedical (LON:OBI) Trading 13.5% Higher – Should You Buy?

Ondine Biomedical Inc. (LON:OBI) traded up 13.5% during mid-day trading on Monday . The stock traded as high as C$14.80 and last traded at C$14.75. 1,840,294 shares changed hands during mid-day trading, an increase of 304% from the average session volume of 455,772 shares. The stock had previously closed at C$13.00.

Ondine Biomedical Price Performance

The company has a quick ratio of 8.26, a current ratio of 1.23 and a debt-to-equity ratio of 11.85. The firm’s fifty day moving average price is C$13.10 and its two-hundred day moving average price is C$10.89. The stock has a market capitalization of C$7.66 billion, a PE ratio of -2.11 and a beta of 0.32.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.